Novel combination therapies targeting the ribosome to treat prostate cancer (PC)

Researchers

  • Professor Ross Hannan (Primary Investigator)
  • Luc Furic (Secondary Investigator)
  • Rick Pearson (Secondary Investigator)
  • Gail Risbridger (Secondary Investigator)

Grant status

Completed-Pending Reports

Grant start date

01/05/2015

Grant funding

  • 2015: $599,492 from Cancer Australia

Updated:  01 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers